HLA
MTEM

Hamilton Lane Advisors’s Molecular Templates, Inc. MTEM Stock Holding History

Hamilton Lane Advisors’s Portfolio MTEM Stock Details MTEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-771
Closed -$160K – 53
2020
Q2 		$160K Buy
+771
New +$179K 0.09% 37

Other funds holding MTEM

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Hamilton Lane Advisors's MTEM Position: Q3 2020 in Review

Hamilton Lane Advisors sold out of Molecular Templates, Inc. (MTEM) in Q3 2020, closing a stake of 771 shares — an estimated $160K sold.

Hamilton Lane Advisors first reported a position in MTEM in Q2 2020 and held it in 1 quarter. The position peaked at $160K in Q2 2020. 103 funds tracked by Wall St. Rank hold MTEM as of Q3 2020.

  • Hamilton Lane Advisors reported no remaining Molecular Templates, Inc. position as of Q3 2020 after selling out during the quarter.
  • Hamilton Lane Advisors sold 771 Molecular Templates, Inc. shares in Q3 2020, an estimated $160K.
  • Hamilton Lane Advisors first reported a position in Molecular Templates, Inc. in Q2 2020 and held it in 1 quarter.
  • Hamilton Lane Advisors's Molecular Templates, Inc. position peaked at $160K in Q2 2020.
  • 103 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q3 2020.

Based on Hamilton Lane Advisors's 13F filing for Q3 2020, filed 15 Oct 2020.